Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chindata Group Holdings Ltd

8.45
+0.0000
Volume:- -
Turnover:- -
Market Cap:3.10B
PE:26.88
High:8.45
Open:8.45
Low:8.45
Close:8.45
Loading ...

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

GlobeNewswire
·
17 Mar

Here's How Much $20,000 Would Earn in a 6-Month CD Right Now

Motley Fool
·
15 Mar

Police Find CD with 8 Videos as Evidence of Ngada Police Chief's Sexual Abuse

Tempo
·
14 Mar

Workhorse announces Kingsburg Truck Center awarded contract from CD of GDS

TIPRANKS
·
06 Mar

Here's How to Play AbbVie Stock as it Enters the Obesity Space

Zacks
·
05 Mar

High Growth Tech Stocks In Europe To Watch March 2025

Simply Wall St.
·
04 Mar

The 3 Biggest Mistakes You Can Make When Investing in CDs

Motley Fool
·
02 Mar

Press Release: Mesoblast Sets Ryoncil(R) Price Based on Economic Value of Treatment With Planned Product Availability This Quarter

Dow Jones
·
27 Feb

Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease

Benzinga
·
24 Feb

Should You Open a 5-Year CD in 2025?

Motley Fool
·
24 Feb

Should You Open a 6-Month CD in 2025?

Motley Fool
·
24 Feb

A Simple Guide to Making Money With CDs

Motley Fool
·
23 Feb

Here's Why Retirees Need to Move Their Cash to a High-Yield Savings Account

Motley Fool
·
22 Feb

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

GlobeNewswire
·
22 Feb

TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis

PR Newswire
·
21 Feb

Wall Street Analysts Are Bullish on Top Technology Picks

TIPRANKS
·
21 Feb